| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.25 | 3e-08 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.21 | 4e-08 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-08 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.21 | 8e-08 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.21 | 5e-06 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |